Search

Search Constraints

You searched for: Author/Creator Murray, Tracey

Search Results

1. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021)

2. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Issue 10349 (30th July 2022)

3. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10325 (12th February 2022)

4. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10387 (6th May 2023)

5. IC‐P‐211: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI‐PARAMETRIC MRI. (1st July 2014)

6. O1‐08‐03: CHARACTERISATION OF TAU FROM P301S MOUSE REVEALS THAT SEED COMPETENT TAU COMPRISE SMALL FIBRILS COMPOSED OF HYPERPHOSPHORYLATED TAU. (1st July 2014)

7. O1–07–04: Rapid and progressive neurofibrillary tangle pathology in a novel in vivo model of tau propagation: Pattern of spread is determined by structural connectivity not spatial proximity. (1st July 2013)

8. O4‐02‐04: BRAIN TEXTURE ANALYSIS AS A BIOMARKER FOR TAUOPATHY IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S. (1st July 2014)

9. O4‐02‐06: AN IMAGING STRATEGY TO CHARACTERISE TAU PATHOLOGY IN VIVO IN A MODEL OF ALZHEIMER'S DISEASE USING MULTI‐PARAMETRIC MRI. (1st July 2014)

10. P3‐049: CHARACTERISATION OF A CO‐CULTURE CELL‐BASED MODEL OF TAU AGGREGATION AND PROPAGATION. (1st July 2014)